Dimitri N Kessaris MDPC

Dimitri N Kessaris MDPC was paid $11.09M by Medicaid between Jan 2018 and May 2024, across 77 billing codes. Its largest line is 88120, — 14% of everything it billed.

33Billing provider infoDIMITRI N KESSARIS MDPC
MANHASSET, NY 11030

33aNPI1154430148assigned 08/30/2006

33bProvider typeUrology Physician

28Total paid$11.09M

24GClaims207,687

24DCodes billed77

24AFirst – last monthJan 2018 – May 2024

Compared with peers

Next to other Urology Physician providers in New York

Rank by total paid#2 of 461

Median peer was paid$6K

This provider vs. median1,921×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	11,443	$727K
2019	20,801	$1.30M
2020	28,057	$1.43M
2021	47,299	$2.70M
2022	46,075	$2.59M
2023	43,913	$1.96M
2024incomplete	10,099	$382K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
88120		14%	4,421	4,329	$1.56M
51728		13%	6,127	6,104	$1.40M
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	11%	4,198	3,954	$1.25M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	11%	10,163	9,487	$1.23M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	8.0%	10,882	9,664	$890K
88112		5.4%	12,409	11,068	$596K
88313		4.9%	12,406	11,064	$541K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	3.8%	2,384	2,365	$422K
76857		2.8%	5,820	5,789	$311K
51784		2.6%	7,514	7,336	$285K
51792		2.5%	1,099	1,088	$276K
76872		2.2%	1,743	1,734	$245K

65 more codes

87556		1.6%	4,369	$174K
51741		1.2%	13,821	$138K
87481		1.2%	4,447	$138K
87640		1.0%	4,574	$115K
99442		1.0%	1,607	$114K
87653		1.0%	4,448	$112K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	4,367	$110K
88360		<1%	1,875	$105K
87081		<1%	17,652	$101K
51798		<1%	8,349	$91K
84153		<1%	3,934	$73K
87563		<1%	2,389	$60K
88342		<1%	975	$58K
84403		<1%	2,166	$57K
99401		<1%	1,697	$54K
88341		<1%	975	$53K
81003		<1%	26,437	$51K
52000		<1%	187	$46K
87150		<1%	337	$43K
93976		<1%	227	$39K
83001		<1%	1,739	$32K
83002		<1%	1,739	$32K
87529		<1%	567	$31K
74178		<1%	85	$26K
84146		<1%	1,269	$23K
87500		<1%	879	$22K
80053	Comprehensive metabolic panel	<1%	2,015	$21K
52214		<1%	25	$19K
36415	Collection of venous blood by venipuncture	<1%	8,698	$15K
87496		<1%	533	$13K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	531	$12K
76775		<1%	205	$12K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	525	$12K
93922		<1%	162	$12K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	510	$12K
76870		<1%	82	$10K
99203	Doctor's office visit, new patient (routine)	<1%	71	$8K
76770		<1%	58	$7K
51729		<1%	13	$5K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	89	$4K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	448	$4K
80048	Basic metabolic panel (calcium, ionized)	<1%	377	$3K
87581		<1%	118	$3K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	39	$3K
87486		<1%	103	$3K
87498		<1%	103	$3K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	58	$3K
87541		<1%	117	$2K
93980		<1%	14	$2K
51797		<1%	13	$1K
54235		<1%	14	$1K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	27	$1K
87186		<1%	128	$1K
87086	Culture, bacterial; quantitative colony count, urine	<1%	127	$925.25
87088		<1%	124	$891.15
81002		<1%	258	$702.60
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	37	$576.23
95921		<1%	12	$534.80
87641		<1%	17	$322.85
87511		<1%	259	$305.26
87532		<1%	582	$49.12
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	63	$12.69
J0270	Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	0%	13	$0.00
77081		0%	15	$0.00
99072		0%	827	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKESSARIS, DIMITRI (PRESIDENT)